US

Amalavoyal Raghav Chari

This inventor holds 0 USPTO granted patents, plus 3 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amalavoyal Raghav Chari. Retrieved from https://idiyas.com/inventor/amalavoyal-raghav-chari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Amalavoyal Raghav Chari: Innovator in Topical Compositions

Introduction

Amalavoyal Raghav Chari is an accomplished inventor based in the United States. He has made significant contributions to the field of topical compositions, particularly those involving corticosteroids. His innovative work focuses on enhancing the effectiveness of these compositions while minimizing the use of certain agents.

Latest Patents

Amalavoyal Raghav Chari holds a patent for "Topical Compositions Comprising A Corticosteroid." This patent details compositions that include a corticosteroid and at least one penetration enhancing agent, while being substantially free of propylene glycol. Although he currently has 0 patents, his work in this area is noteworthy.

Career Highlights

Chari is associated with Promius Pharma LLC, where he applies his expertise in pharmaceutical formulations. His role at the company allows him to contribute to the development of innovative products that aim to improve patient outcomes.

Collaborations

Throughout his career, Amalavoyal has collaborated with notable colleagues such as Sateesh Kandavilli and Madhusudhan Bommagani. These collaborations have likely enriched his work and expanded the scope of his research.

Conclusion

Amalavoyal Raghav Chari is a dedicated inventor whose work in topical compositions demonstrates his commitment to innovation in the pharmaceutical industry. His contributions, although currently limited in patent count, reflect a promising trajectory in enhancing therapeutic formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…